(Q46082218)

19 December 2017

title

Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma (English)

1 reference

19 December 2017

11

T F Cloughesy

1 reference

19 December 2017

author name string

J A Carrillo

1

1 reference

19 December 2017

A Lai

2

1 reference

19 December 2017

P L Nghiemphu

3

1 reference

19 December 2017

H J Kim

4

1 reference

19 December 2017

H S Phillips

5

1 reference

19 December 2017

S Kharbanda

6

1 reference

19 December 2017

P Moftakhar

7

1 reference

19 December 2017

S Lalaezari

8

1 reference

19 December 2017

W Yong

9

1 reference

19 December 2017

B M Ellingson

10

1 reference

19 December 2017

W B Pope

12

1 reference

19 December 2017

language of work or name

1 reference

9 February 2012

1 reference

19 December 2017

American Journal of Neuroradiology

published in

1 reference

19 December 2017

volume

33

1 reference

19 December 2017

issue

7

1 reference

19 December 2017

page(s)

1349-1355

1 reference

19 December 2017

Antiangiogenic therapies for high-grade glioma

cites work

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Genetic alterations and signaling pathways in the evolution of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

IDH1 and IDH2 mutations in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Mutant metabolic enzymes are at the origin of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Diagnostic and prognostic markers in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Prognostic significance of preoperative MRI scans in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Pathological and clinical features of cystic and noncystic glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Prognostic significance of contrast-enhancing anaplastic astrocytomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Germline p53 gene mutations in subsets of glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Genetic signature of adult gliomas and correlation with MRI features

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Microarray analysis of MRI-defined tissue samples in glioblastoma reveals differences in regional expression of therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Identification of noninvasive imaging surrogates for brain tumor gene-expression modules

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Management of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Imaging patterns of multifocal gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Magnetic resonance perfusion and permeability imaging in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Lack of complete 1p19q deletion in a consecutive series of 12 WHO grade II gliomas involving the insula: a marker of worse prognosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

High rate of deletion of chromosomes 1p and 19q in insular oligodendroglial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Glioblastomas with oligodendroglial component - common origin of the different histological parts and genetic subclassification.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Cerebral glioblastoma with oligodendrogliomal component: analysis of 36 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

Monoclonal antibody specific for IDH1 R132H mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2950

21 January 2018

Identifiers

DOI

10.3174/AJNR.A2950

1 reference

19 December 2017

1 reference

19 December 2017